Loading...
The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
PURPOSE: AMD3100, an antagonist of the CXCR4 chemokine receptor is soon to be used clinically for the peripheral mobilization of hematopoietic stem cells (HSCs) in patients with multiple myeloma. AMD3100 has been shown to activate a G protein coupled with CXCR4 and thus acts as a partial CXCR4 agoni...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Cancer Association
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3021742/ https://ncbi.nlm.nih.gov/pubmed/21253325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.4.225 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|